SFM
CNST

Sphera Funds Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Sphera Funds Management’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-40,162
Closed -$544K – 123
2019
Q1 		$544K Sell
40,162
-30,000
-43% -$269K 0.05% 97
2018
Q4 		$281K Buy
+70,162
New +$423K 0.03% 96

Other funds holding CNST

PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Sphera Funds Management's CNST Position: Q2 2019 in Review

Sphera Funds Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q2 2019, closing a stake of 40,162 shares — an estimated $544K sold.

Sphera Funds Management first reported a position in CNST in Q4 2018 and held it in 2 quarters. The position peaked at $544K in Q1 2019. 50 funds tracked by Wall St. Rank hold CNST as of Q2 2019.

  • Sphera Funds Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Sphera Funds Management sold 40,162 Constellation Pharmaceuticals, Inc. shares in Q2 2019, an estimated $544K.
  • Sphera Funds Management first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2018 and held it in 2 quarters.
  • Sphera Funds Management's Constellation Pharmaceuticals, Inc. position peaked at $544K in Q1 2019.
  • 50 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2019.

Based on Sphera Funds Management's 13F filing for Q2 2019, filed 14 Aug 2019.